ArticleACS omega2024

Regorafenib Attenuates Osteoclasts Differentiation by Inhibiting the NF-κB, NFAT, ERK, and p38 Signaling Pathways.

Lin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.